Education
About Us
Working with TipRanks
Follow Us
Verastem (VSTM)
NASDAQ:VSTM
Earnings Data
Report Date
Oct 30, 2025After Close (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-0.62Last Year’s EPS
-0.6Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflected a positive sentiment, with significant achievements such as the early FDA approval and successful commercial launch of AVMAPKI FAKZYNJA CO-PACK. These positive developments were partially offset by increased R&D expenses and net loss. However, the highlights significantly outweigh the lowlights, indicating strong momentum and future potential.Company Guidance
FDA Approval of AVMAPKI FAKZYNJA CO-PACK
Achieved FDA approval for AVMAPKI FAKZYNJA CO-PACK for KRAS-mutated recurrent LGSOC nearly 2 months ahead of schedule. This marks the first-ever truly novel/novel drug combination approved in oncology.
Successful Commercial Launch
Generated $2.1 million in net product revenue within the first 6 weeks of launch, indicating strong early traction and operational excellence.
Broad Insurance Coverage
Secured coverage from major insurers in the U.S., including the three largest PBMs, representing over 80% of lives.
Strengthened Financial Position
Completed a $75 million private placement, ending the quarter with $164.3 million in cash, cash equivalents, and investments.
Expansion of Distribution Network
Entered into multiple agreements with specialty distributors and oncology group purchasing organizations.
VSTM Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
VSTM Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 07, 2025 | $5.62 | $6.74 | +19.93% |
May 13, 2025 | $7.46 | $7.13 | -4.42% |
Mar 20, 2025 | $6.82 | $6.65 | -2.49% |
Nov 06, 2024 | $3.87 | $3.60 | -6.98% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Verastem (VSTM) report earnings?
Verastem (VSTM) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).
What is Verastem (VSTM) earnings time?
Verastem (VSTM) earnings time is at Oct 30, 2025, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is VSTM EPS forecast?
VSTM EPS forecast for the fiscal quarter 2025 (Q3) is -0.62.